WallStreetZenWallStreetZen

NASDAQ: LFCR
Lifecore Biomedical Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their LFCR stock forecasts and price targets.

Forecast return on equity

Is LFCR forecast to generate an efficient return?
Company
N/A
Industry
25.07%
Market
29.28%

Forecast return on assets

Is LFCR forecast to generate an efficient return on assets?
Company
N/A
Industry
13.22%

LFCR revenue forecast

What is LFCR's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$127.0M+22.96%
Avg 2 year Forecast
$146.0M+41.4%
LFCR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LFCR revenue growth forecast

How is LFCR forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
22.96%
Industry
12.43%
Market
13.86%
LFCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LFCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LFCR vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
LFCR$5.31N/AN/A
OPTN$1.46$4.50+208.22%Strong Buy
OGI$2.15N/AN/A
ZOM$0.15N/AN/A
EBS$2.53$5.00+97.63%Strong Buy

Lifecore Biomedical Stock Forecast FAQ

What is LFCR's revenue growth forecast for 2024-2025?

(NASDAQ: LFCR) Lifecore Biomedical's forecast annual revenue growth rate of 22.96% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 12.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.86%.

Lifecore Biomedical's revenue in 2024 is $103,269,000.On average, 1 Wall Street analysts forecast LFCR's revenue for 2024 to be $3,878,819,386, with the lowest LFCR revenue forecast at $3,878,819,386, and the highest LFCR revenue forecast at $3,878,819,386.

In 2025, LFCR is forecast to generate $4,460,646,876 in revenue, with the lowest revenue forecast at $4,460,646,876 and the highest revenue forecast at $4,460,646,876.

If you're new to stock investing, here's how to buy Lifecore Biomedical stock.

What is LFCR's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: LFCR) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.22%.

What is LFCR's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: LFCR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.